Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FT3R
|
|||
| Drug Name |
Tildrakizumab
|
|||
| Synonyms |
UNII-DEW6X41BEK; DEW6X41BEK; Tildrakizumab [USAN:INN]; SCH 900222
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Approved | [1] | |
| Company |
Sun Pharma
|
|||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.